Latest News

SpaceX has massive capital spending plans, but it's really just one example of the huge demand Brookfield Renewable is serving.

Archer faces many regulatory and operational hurdles before it can launch an air taxi service.

Together they make up about 15% of the index. What might two days of earnings reports do to an S&P 500 fund?

Long-term earnings growth is going to be key for S&P 500 performance.

Cerebras and Marvell are chasing AI growth in very different ways. Here's how each could challenge AMD, and the risks investors should weigh.

President Luiz Inácio Lula da Silva narrowly won re-election vs. Flávio Bolsonaro.

You might be able to start all over if you can do one thing.

The stock climbed this year, until recently.

Bitcoin's future growth rate could look very different from its historical growth rate.

The average retired worker collects $2,088.79 monthly, but beating that benchmark doesn't guarantee retirement security.

The fiber-optics maker's earnings are still rising around 30%. Has the sell-off gone too far?

Sandisk stock has risen more than 3,000% since its February 2025 IPO.

Bristol Myers Squibb is facing a sizable patent cliff, but that's not unusual in the pharma sector.

Useful quantum computing is just years away.

These five insurance stocks each sport decades-long track records of consecutive annual dividend growth.

NuScale has a competitive edge that is made dull by its legal troubles and lack of secured business.

AI-driven domain growth is accelerating, but the real upside lies in .web's unregulated pricing and new security services launching next year.

Elon Musk's success is closely linked to that of his two biggest businesses.

The company's rapid growth has created a scaled banking powerhouse.

Ternus faces real challenges as he follows in Cook's footsteps.

The popular REIT offers monthly distributions that are growing.

Grab stock has continued to lose ground this year, but growth for its business tells a different story.

A biosimilar approval target and supply-chain fixes set up margin expansion as core growth offsets legacy drug headwinds.

Could The Metals Company be on the verge of a massive bull run?

Claiming at 62 gives you an eight-year head start, but the monthly gap with age 70 is far larger than most realize.